Quantcast

Latest genotype Stories

2014-03-03 16:25:42

-- SVR(12) rates of 99 percent with and without ribavirin were achieved in genotype 1b patients new to treatment BOSTON, March 3, 2014 /PRNewswire/ -- The first detailed results from AbbVie's (NYSE: ABBV) pivotal phase III study, PEARL-III, were presented today as part of the 21st Conference on Retroviruses and Opportunistic Infections (CROI) press conference and will also be presented as a late-breaker at the conference on March 4. PEARL-III evaluated the efficacy and safety of 12...

2014-02-19 08:30:00

ALBANY, New York, February 19, 2014 /PRNewswire/ -- ResearchMoz.us includes new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019 [http://www.researchmoz.us/hepatitis-c-therapeutics-in-major-developed-markets-to-2019-outstanding-recent-approvals-and-late-stage-pipeline-to-transform-clinical-and-commercial-landscape-report.html ] " to its huge collection of research reports. Researchmoz presents this most up-to-date research on...

2014-02-02 23:02:36

ResearchMoz include new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019 - Industry Size, Shares, Growth, Trends and Forecast 2019" to its huge collection of research reports. Browse reports in Therapeutic Area - http://www.researchmoz.us/therapeutic-area-market-reports-37.html. Albany, NY (PRWEB) February 02, 2014 “Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to...

2014-01-31 08:25:10

- Ninety-nine percent SVR(12) rates with and without ribavirin in certain patient types NORTH CHICAGO, Ill., Jan. 31, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced the completion of its phase III clinical program and released results of four additional studies designed to assess AbbVie's investigational all-oral, interferon-free therapy with and without ribavirin (RBV) in patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection. These results described below...

Researchers Discover Molecular Causes For Sex Determination In Honey Bees
2013-12-31 06:56:40

redOrbit Staff & Wire Reports – Your Universe Online New research appearing in the December issue of the journal Cell Biology puts together the final pieces in a puzzle 200 years in the making – determining the molecular evolution in the genes that separate male honey bees from female ones. Lead author Martin Beye, a professor with the Institute of Evolutionary Genetics at the University of Düsseldorf, and his colleagues studied 14 natural sequence variants of the complementary...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related